Literature DB >> 9639473

Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma.

S A Goldman1, E Baker, R J Weyant, M R Clarke, J N Myers, M T Lotze.   

Abstract

OBJECTIVES: To determine if survival and recurrence rates for patients with squamous cell carcinoma of the tongue correlate with the degree of dendritic cell (DC) infiltration of the primary tumor or adjacent tongue tissue and if there is an association between tumor or nodal stage and DC infiltration.
DESIGN: Hospital and office medical records were reviewed to obtain 5-year follow-up data. Original pathology specimens were recut and stained for the cell surface markers S100 and CD 1a. The number of DCs present in the specimens was quantified microscopically and compared statistically with patient outcome and staging.
SETTING: A university hospital. PATIENTS: All patients who underwent resection of primary squamous cell carcinoma of the tongue from January 1, 1987, through December 31, 1990, for whom 5-year follow-up data and original pathology specimens were available (N=43). MAIN OUTCOME MEASURES: Time to recurrence, death, or both.
RESULTS: Patients who had greater numbers of CD1a-positive DCs adjacent to tumor had improved survival (P=.02) and decreased recurrence rates (P=.06). The other subpopulations of DCs examined were not associated with survival or recurrence. In addition, the number of CD 1a-positive DCs in peritumoral epithelium decreased as the tumor stage increased (P=.01) and if nodal metastases were present (P=.05).
CONCLUSIONS: Dendritic cells are antigen-presenting cells that are thought to play a major role in the antitumor immune response. The CD1a surface antigen has been shown to mediate T-cell interactions. The association between CD1a-positive peritumoral DCs and patient outcome suggests an important function for this cell population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639473     DOI: 10.1001/archotol.124.6.641

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  18 in total

Review 1.  Chemokines and dendritic cell traffic.

Authors:  S Sozzani; P Allavena; A Vecchi; A Mantovani
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

2.  Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.

Authors:  Nghia Nguyen; Emily Bellile; Daffyd Thomas; Jonathan McHugh; Laura Rozek; Shama Virani; Lisa Peterson; Thomas E Carey; Heather Walline; Jeffery Moyer; Matthew Spector; Daniel Perim; Mark Prince; Scott McLean; Carol R Bradford; Jeremy M G Taylor; Gregory T Wolf
Journal:  Head Neck       Date:  2016-02-16       Impact factor: 3.147

Review 3.  Immunobiology and immunotherapy of head and neck cancer.

Authors:  T L Whiteside
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

4.  Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.

Authors:  Zoya B Kurago; Aroonwan Lam-ubol; Anton Stetsenko; Chris De La Mater; Yiyi Chen; Deborah V Dawson
Journal:  Head Neck Pathol       Date:  2008-03

Review 5.  The Microenvironment of Tongue Cancer.

Authors:  Want Tao; Zeng Li-Juan; Li Kan; Li Jing-Yuan; Liu Xiang-Qi; Liang Yu-Jie
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study.

Authors:  Gregory T Wolf; Douglas B Chepeha; Emily Bellile; Ariane Nguyen; Daffyd Thomas; Jonathan McHugh
Journal:  Oral Oncol       Date:  2014-10-03       Impact factor: 5.337

7.  Quantification of dendritic cells and osteoclasts in the bone marrow of patients with monoclonal gammopathy.

Authors:  Nicolas Josselin; Hélène Libouban; Mamoun Dib; Norbert Ifrah; Erick Legrand; Michel Félix Baslé; Maurice Audran; Daniel Chappard
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

Review 8.  Langerhans cells and their role in oral mucosal diseases.

Authors:  Juhi Upadhyay; Ram B Upadhyay; Pankaj Agrawal; Shweta Jaitley; Rhitu Shekhar
Journal:  N Am J Med Sci       Date:  2013-09

9.  CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients.

Authors:  Vivian Labovsky; Norma Alejandra Chasseing; María Belén Giorello; Ayelén Matas; Pablo Marenco; Kevin Mauro Davies; Francisco Raúl Borzone; María de Luján Calcagno; Hernán García-Rivello; Alejandra Wernicke; Leandro Marcelo Martinez
Journal:  Breast Cancer       Date:  2021-07-09       Impact factor: 4.239

10.  CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer.

Authors:  B J Coventry; J Morton
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.